HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 34/1/125    most recent 09031936.00160508v1 Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Murray, M. P. Articles by Hill, A. T. PubMed PubMed Citation Articles by Murray, M. P. Articles by Hill, A. T.

Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis

Dept of Respiratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.

CORRESPONDENCE: M. P. Murray, Royal Infirmary of Edinburgh, Department of Respiratory Medicine, 51 Little France Crescent, Old Dalkeith Road, Edinburgh, EH16 4SA, UK. E-mail: maevemurray{at}hotmail.com

Keywords: Bronchiectasis, cough, health-related quality of life

Received: October 24, 2008
Accepted January 11, 2009

Health-related quality of life is a potentially important marker for evaluating existing and new therapies in bronchiectasis. The Leicester Cough Questionnaire (LCQ) is a symptom specific questionnaire designed to assess the impact of cough severity, a major symptom of bronchiectasis. This study aimed to validate the LCQ in bronchiectasis.

The validity, responsiveness and reliability of the LCQ were assessed as follows: ability to discriminate severe and mild disease; change in score following antibiotic treatment for exacerbations; repeatability over a 6-month period in stable disease; and comparison with the St George's Respiratory Questionnaire (SGRQ).

In total, 120 patients (51 with severe disease, 29 with moderate disease and 40 with mild disease) completed the LCQ and SGRQ. The area under the receiver–operator curve was good for both severe and mild disease (0.84 and 0.80 respectively, p<0.0001). Following 2 weeks' antibiotic treatment, the median LCQ score (interquartile range) improved from 11.3 (9.3–13.7) to 17.8 (15–18.8) (p<0.0001). The LCQ score was repeatable over 6 months in stable disease (intraclass correlation coefficient of 0.96 (95%CI 0.93–0.97), p<0.0001). Correlation between the LCQ and SGRQ scores was -0.7 in both stable disease and exacerbations (p<0.0001).

The LCQ can discriminate disease severity, is responsive to change and is reliable for use in non-cystic fibrosis bronchiectasis.